Netherlands Cancer Institute receives US grant for pancreatic cancer research


Two years ago, researchers at the Netherlands Cancer Institute discovered a new weakness of pancreatic cancers. Currently, they are in the process of harnessing that knowledge to develop a combination therapy, and their lab work so far has produced promising results. Now, the American Pancreatic Cancer Collective has awarded the team a research grant of 3.8 million dollars, allowing them to start working towards a clinical trial.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.